Citation tools

MIYAJIMA, KEIICHIRO et al "Comparison of Quality of Life and Injection Site Reactions After Switching from Degarelix 80 mg to 480 mg in Advanced Prostate Cancer: A Prospective Trial." Anticancer Research 43.4 (2023): 1611-1621. Web. 29 Sept2023.